I have volunteered for The Leukemia & Lymphoma Society (LLS) for almost a year now. Wow. I can’t believe I’ve been with Team In Training that long. And I can’t believe how my life has changed since that fateful day I walked into Market Street for the informational meeting. Ohhh how my life has changed. Changed all because of Team In Training. All because of LLS.
When I read the below, I couldn’t help but have the feeling that we had some sort of part in this. We meaning me and you. Now, I know that sounds ridiculous but it’s how I felt. Its how we should all feel. So, I wanted to thank all of you out there in blogland that donated to me and this wonderful cause. Thank you. YOU did this…
LLS Funded Researcher is on Time Magazine’s List of 100 Most Influential People
Dear Friend of LLS:
I am pleased to share exciting news about Larry Kwak, M.D., Ph.D., a researcher funded by The Leukemia & Lymphoma Society. Dr. Kwak was recently named one of TIME Magazine's "100 Most Influential People," for his role in advancing custom-made vaccines for patients with lymphoma.
Dr. Kwak, professor and chair of the Department of Lymphoma and Myeloma at The University of Texas M.D. Anderson Cancer Center in Houston, has focused his work on harnessing the power of the immune system of patients with follicular non-Hodgkin's lymphoma to fight their cancer. The vaccines are developed by taking proteins from the patient's own tumor, training them to find and kill lymphoma cells and then injecting them back into the patient. Currently in late stage clinical trials, the vaccines have been shown to extend disease-free survival for more than a year.
In 2007, LLS awarded Dr. Kwak a five-year, $6.25 million Specialized Center of Research grant, our most prestigious research award. These grants are distinctive in that they encourage at least three laboratories at the same or different institutions to work together. In addition to continuing his work on the personalized lymphoma vaccines, this grant is enabling Dr. Kwak to expand his research to develop immunotherapies for patients with leukemia and myeloma as well.
Throughout his distinguished career, Dr. Kwak has been on the cutting edge of researching and developing novel immunotherapies that are already showing a clear benefit for patients with cancer. We are proud of Dr. Kwak's well-deserved recognition and are honored to have played a role in helping to advance this life-saving work.
To read more about Dr. Kwak's inclusion in the "2010 Time 100" please visit Time Magazine's website, and to learn more about our Research programs visit www.LLS.org. Please join us in taking pride in Dr. Kwak's achievements.
John E. Walter
President & CEO